SHAIK, MOHAMMED MONSOOR
 Distribuzione geografica
Continente #
EU - Europa 2.973
AS - Asia 1.407
NA - Nord America 1.114
SA - Sud America 194
AF - Africa 40
OC - Oceania 3
Totale 5.731
Nazione #
SE - Svezia 1.869
US - Stati Uniti d'America 1.067
IT - Italia 609
SG - Singapore 423
CN - Cina 280
VN - Vietnam 198
HK - Hong Kong 175
BR - Brasile 140
RU - Federazione Russa 131
IN - India 68
GB - Regno Unito 60
BD - Bangladesh 59
FR - Francia 56
DE - Germania 41
KR - Corea 41
NL - Olanda 39
ES - Italia 27
JP - Giappone 27
FI - Finlandia 26
IE - Irlanda 26
PL - Polonia 26
ID - Indonesia 23
CA - Canada 22
TR - Turchia 20
AR - Argentina 19
PK - Pakistan 16
DK - Danimarca 15
IQ - Iraq 14
ZA - Sudafrica 14
MX - Messico 13
CL - Cile 10
BE - Belgio 9
AT - Austria 8
MA - Marocco 8
SA - Arabia Saudita 8
UA - Ucraina 8
CO - Colombia 7
EC - Ecuador 7
MY - Malesia 7
PH - Filippine 7
UZ - Uzbekistan 7
IL - Israele 6
VE - Venezuela 6
LB - Libano 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 5.731
Città #
Stockholm 1.866
Singapore 272
Milan 223
San Jose 170
Hong Kong 164
Ashburn 147
Ho Chi Minh City 68
Los Angeles 68
Hefei 64
Hanoi 56
Santa Clara 55
New York 42
Seoul 38
Beijing 34
Council Bluffs 34
Dallas 33
Rome 32
Chicago 29
Buffalo 27
Dublin 27
Tokyo 26
São Paulo 25
Helsinki 20
Boardman 19
Frankfurt am Main 18
Jakarta 18
Shanghai 18
Warsaw 18
Amsterdam 16
Florence 16
Bologna 15
Hyderabad 14
Maastricht 14
Paris 14
Chennai 13
The Dalles 13
Orem 12
Turin 12
Washington 12
Copenhagen 11
Lauterbourg 11
Sassuolo 11
Johannesburg 10
London 10
Brescia 9
Denver 9
Houston 9
Naples 9
Philadelphia 9
Atlanta 8
Desio 8
Nuremberg 8
Barnet 7
Boston 7
Brooklyn 7
Haiphong 7
Hangzhou 7
Montreal 7
Poplar 7
Rometta 7
Sorbolo 7
Tashkent 7
Toronto 7
Baghdad 6
Dhaka 6
Istanbul 6
Moscow 6
Phoenix 6
Santiago 6
Columbus 5
Da Nang 5
Guangzhou 5
Kent 5
Krakow 5
Kuala Lumpur 5
Lappeenranta 5
Mumbai 5
New Delhi 5
Pisogne 5
Reading 5
San Giuliano Terme 5
Vienna 5
Berlin 4
Bexley 4
Charlotte 4
City of London 4
Como 4
Edinburgh 4
Figino 4
Heverlee 4
Inzago 4
Medellín 4
Mexico City 4
Monza 4
Munich 4
Nairobi 4
Pasadena 4
Saint-Martin-d'Hères 4
Salò 4
San Francisco 4
Totale 4.134
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.959
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 403
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 295
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 287
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 275
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 275
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 265
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 244
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 227
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 225
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection 201
Self-Activated Fluorescent Hydroxyapatite Nanoparticles: A Promising Agent for Bioimaging and Biolabeling 174
Ellagic acid containing collagen-chitosan scaffolds as potential antioxidative bio-materials for tissue engineering applications 157
Antioxidant-antibacterial containing bi-layer scaffolds as potential candidates for management of oxidative stress and infections in wound healing 155
Novel melt-down neutralization method for synthesis of chitosan-silver scaffolds for tissue engineering applications 144
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 134
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 71
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 56
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 55
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 50
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 44
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 42
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 40
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 36
Totale 5.814
Categoria #
all - tutte 14.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202330 0 0 0 0 0 0 0 0 0 18 7 5
2023/2024226 1 7 48 18 12 23 27 2 22 18 17 31
2024/2025989 29 66 95 62 68 52 60 33 77 149 85 213
2025/20264.474 229 141 153 285 234 110 332 129 273 2.200 120 268
2026/202795 95 0 0 0 0 0 0 0 0 0 0 0
Totale 5.814